Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$2.8 - $5.46 $51,153 - $99,748
18,269 Added 125.48%
32,828 $95,000
Q3 2022

Nov 14, 2022

BUY
$2.85 - $8.73 $62 - $192
22 Added 0.15%
14,559 $55,000
Q2 2022

Aug 15, 2022

BUY
$4.69 - $9.84 $75 - $157
16 Added 0.11%
14,537 $113,000
Q1 2022

May 16, 2022

BUY
$8.44 - $16.89 $122,557 - $245,259
14,521 New
14,521 $135,000

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $1.08B
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.